<DOC>
	<DOCNO>NCT01466543</DOCNO>
	<brief_summary>The purpose study determine whether Zydena ( Udenafil ) effect cerebral blood flow peripheral blood viscosity normal subcortical vascular cognitive impairment subject .</brief_summary>
	<brief_title>Effect Zydena ( Udenafil ) Cerebral Blood Flow Peripheral Blood Viscosity</brief_title>
	<detailed_description>Udenafil newly develop selective phosphodiesterase type 5 inhibitor ( PDE5i ) . Since PDE5i known relax smooth muscle cell , suggest PDE5i may dilate cerebral vessel lead increase cerebral blood flow . The main mechanism subcortical vascular cognitive impairment hypoperfusion brain . Therefore , study , investigator investigate whether Udenafil increase cerebral blood flow also low peripheral blood viscosity normal subcortical vascular cognitive impairment subject .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<mesh_term>Udenafil</mesh_term>
	<criteria>Normal control group Normal cognition detail neuropsychological test Brain MRI scan minimal white matter hyperintensities Subcortical vascular mild cognitive impairment ( svMCI ) Clinical diagnosis svMCI Brain MRI scan severe white matter hyperintensities Contraindications phosphodiesterase type 5 ( Zydena , Udenafil )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Vascular dementia</keyword>
	<keyword>Subcortical vascular dementia</keyword>
	<keyword>Phosphodiesterase 5</keyword>
	<keyword>Udenafil</keyword>
</DOC>